Literature DB >> 5007843

Prostaglandin-oxytocin enhancement and potentiation and their clinical applications.

A Gillespie.   

Abstract

The pharmacological phenomena of enhancement and potentiation of uterine response occur respectively when combinations of some prostaglandins and oxytocin are given serially and simultaneously to a patient. Employing these phenomena allows small doses of the drugs to achieve the same effects as a large dose given alone. In a pilot study of the use of the combination of prostaglandin and oxytocin for the induction of mid-trimester abortion seven of nine women were aborted within 48 hours. Side effects attributable to prostaglandin were eliminated or reduced in severity.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5007843      PMCID: PMC1787121          DOI: 10.1136/bmj.1.5793.150

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  Concentrated oxytocin solution for therapeutic interruption of midtrimester pregnancy. A preliminary report.

Authors:  M S BURNHILL; J A GAINES; A F GUTTMACHER
Journal:  Obstet Gynecol       Date:  1962-07       Impact factor: 7.661

2.  Therapeutic abortion by local administration of prostaglandin.

Authors:  N Wiqvist; M Bygdeman
Journal:  Lancet       Date:  1970-10-03       Impact factor: 79.321

3.  Therapeutic abortion using prostaglandin F2alpha.

Authors:  S M Karim; G M Filshie
Journal:  Lancet       Date:  1970-01-24       Impact factor: 79.321

4.  The use of an "unnatural" prostaglandin in the termination of pregnancy.

Authors:  A Gillespie; J M Beazley; D A van Dorp
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-04

5.  Interaction of E prostaglandins and syntocinon on the pregnant human myometrium.

Authors:  H C Brummer
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-04

6.  Use of prostaglandin E2 for therapeutic abortion.

Authors:  S M Karim; G M Filshie
Journal:  Br Med J       Date:  1970-07-25

7.  The action of ketonic prostaglandins on the guinea-pig myometrium.

Authors:  P C Clegg; W J Hall; V R Pickles
Journal:  J Physiol       Date:  1966-03       Impact factor: 5.182

  7 in total
  10 in total

Review 1.  Chemotherapeutic induction of labour. A rational approach.

Authors:  E M Xenakis; J M Piper
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 2.  Clinical use of prostaglandins in obstetrics.

Authors:  A Gillespie
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. 1973.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

4.  Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear.

Authors:  H Juan; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Therapeutic abortion by a single extra-amniotic instillation of prostaglandin f2alpha.

Authors:  P Fylling; A Refsdal
Journal:  Arch Gynakol       Date:  1974

6.  Induction of abortion by intravenous infusions of prostaglandin F 2 .

Authors:  E Dreher; T H Lippert
Journal:  Arch Gynakol       Date:  1972

7.  Regulation of bradykinin-induced cyclic amp response by quinacrine and prostaglandin E2 and F2 alpha in human synovial fibroblasts.

Authors:  J V Fahey; D S Newcombe
Journal:  Inflammation       Date:  1979-07       Impact factor: 4.092

8.  Intracervical application of PGE2-gel combined with early intravenous infusion of oxytocin for induction of term labor in women with unripe cervix.

Authors:  G Ekman; U Ulmsten; L Wingerup
Journal:  Arch Gynecol       Date:  1983

Review 9.  Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid mild analgesics.

Authors:  G A Higgs
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.